A new era in neuroregeneration | Annie Kathuria | TEDxBoston

Quick Overview

Annie Kathuria presents a multi-stage plan, "Crossing the Transplantable Gap," to advance the field of neuroregeneration for Traumatic Brain Injury (TBI) by creating transplantable brain organoids that integrate and function within a host, moving from bench research to preclinical trials and eventually to the bedside.

Key Points: TBI affects over 20 million people worldwide annually, leaving 55 million living with TBI-related disabilities, often with the grim prognosis that the brain cannot regenerate. The research focuses on overcoming the transplantable gap by developing transplantable brain organoids that integrate with host tissues, including the formation of blood vessels and electrical function. The multi-step plan ("Crossing the Transplantable Gap") involves eight stages: 1) iPSC Protocols & Master Bank-Transplant lines (GMP/GLP), 2) Cell Lineage-Relevance, 3) Omics ECM/Signals Identification, 4) Radial Glia BM Attachment, 5) Multi-Region Integration, 6) Cell Viability (Mean by Marker), 7) Early BBB Formation, Vascular and Electrical Function, and 8) Transport and Storage. The team demonstrated that their organoids possess both cerebral and endothelial components (01:51) and exhibit key functional milestones like vascular network formation and electrical signaling (04:08, 05:50). Preclinical models, both small (e.g., open field and touchscreen testing) and large (using an electromagnetic impactor for TBI modeling), are being used to validate safety, viability, and functional recovery (06:19, 06:43). The ultimate call to action is collaborative, involving tissue engineers, biomaterials experts, and neurosurgeons to move GMP-grade, clinically compatible iPSC cell lines through preclinical trials towards FDA readiness (07:01).

Context: Annie Kathuria delivers a TEDxBoston talk addressing the severe challenge of Traumatic Brain Injury (TBI), highlighting the devastating question patients face: "Will I ever recover?" because the brain typically cannot regenerate. She introduces her team's ambitious research program focused on regenerative medicine, specifically using induced pluripotent stem cells (iPSCs) to grow complex, transplantable brain organoids that could eventually replace damaged neural tissue and restore function.